Status:
COMPLETED
Prevention of Asthma Relapse After Discharge From Emergency
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the Symbicort® Turbuhaler® to both Pulmicort® Turbuhaler® and Bricanyl® Turbuhaler® for the treatment of asthma after discharge from the emergency room
Eligibility Criteria
Inclusion
- 18 - 65 years of age
- Presenting at a study emergency department with an asthma exacerbation
Exclusion
- Admission to hospital
- Patients receiving more than 2000 µg/day of beclomethasone equivalent inhaled corticosteroids (1000 µg/day fluticasone or 1600 µg/day budesonide)
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2007
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00326053
Start Date
May 1 2006
End Date
May 1 2007
Last Update
January 24 2011
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Calgary, Alberta, Canada
2
Research Site
Edmonton, Alberta, Canada
3
Research Site
Lethbridge, Alberta, Canada
4
Research Site
St. Albert, Alberta, Canada